Previous 10 | Next 10 |
2024-05-22 13:27:58 ET Moderna Inc (NASDAQ: MRNA) is up more than 10% on Wednesday after a child tested positive for avian influenza in Australia. Why is significant for Moderna stock? It’s the first human case of bird flu recorded in the land down under. The child tested...
2024-05-22 07:10:00 ET Moderna (NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this hot technology for years to help it save crucial time in the laboratory. For example, Moderna uses AI to...
Moderna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT CAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on mRNA-4157 (V940), an investigational mRNA individualized neoantigen therapy, have been accepted for p...
2024-05-21 16:12:19 ET Moderna ( NASDAQ: MRNA ) shares traded in the green on Tuesday, making it the seventh consecutive day of gains. Stock closed up 1.90% at $143.69.... Read the full article on Seeking Alpha For further details see: Moderna trades in the green for...
2024-05-20 17:17:41 ET Summary Moderna's individualized neoantigen therapy, mRNA-4157, is a cancer vaccine with potential in multiple cancer types. mRNA-4157 has produced compelling results in stage III/IV melanoma patients, where a combination with pembrolizumab reduced the risk ...
2024-05-18 14:52:07 ET More on GSK, Johnson & Johnson, etc. Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript) Johnson & Johnson (JNJ) ...
2024-05-17 14:40:17 ET More on Stocks Hasbro: Fairly Priced As Turnaround Game Plan Is Playing Out Tesla is reportedly considering data centers in China FAA operational hold on United Airlines remains intact - update Moderna vaccine patent upheld by European ...
2024-05-17 13:25:19 ET More on Moderna Moderna Q1: A Promising Pipeline Is Undervalued Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript Moderna, Inc. 2024 Q1 - Results - Earnings Call Presentation Evercore says biotech ‘winter is finally thawing...
2024-05-17 05:40:00 ET Novavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soared -- in fact, Novavax rose the most, gaining 2,700% in 2020 compared to a 400% increase for ...
2024-05-16 14:08:55 ET Billionaire investor Philippe Laffont's Coatue Management exited its stakes in Apple ( NASDAQ: AAPL ) and Walt Disney ( NYSE: DIS ), picked up new positions in Qualcomm ( NASDAQ: QCOM ) and Broadcom ( AVGO ), and massively increased its hol...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...